Todd E. Zavodnick
2018
In 2018, Todd E. Zavodnick earned a total compensation of $1.5M as Former Chief Commercial Officer and President, Aesthetics & Therapeutics at Revance Therapeutics, a 52% decrease compared to previous year.
Compensation breakdown
| Option Awards | $824,577 |
|---|---|
| Salary | $363,506 |
| Stock Awards | $247,775 |
| Other | $55,460 |
| Total | $1,491,318 |
Zavodnick received $824.6K in option awards, accounting for 55% of the total pay in 2018.
Zavodnick also received $363.5K in salary, $247.8K in stock awards and $55.5K in other compensation.
Rankings
In 2018, Todd E. Zavodnick's compensation ranked 7,191st out of 14,244 executives tracked by ExecPay. In other words, Zavodnick earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,191 out of 14,244 | 50th |
Division Manufacturing | 2,778 out of 5,765 | 52nd |
Major group Chemicals And Allied Products | 1,045 out of 2,128 | 51st |
Industry group Drugs | 882 out of 1,817 | 52nd |
Industry Pharmaceutical Preparations | 689 out of 1,391 | 51st |
Source: SEC filing on March 25, 2019.
Zavodnick's colleagues
We found six more compensation records of executives who worked with Todd E. Zavodnick at Revance Therapeutics in 2018.
2018
L Browne
Revance Therapeutics
Chief Executive Officer
2018
Caryn McDowell
Revance Therapeutics
General Counsel
2018
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
2018
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
2018
Lauren Silvernail
Revance Therapeutics
Chief Financial Officer
2018
Cyril Allouche
Revance Therapeutics